UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 208

Sortiert nach

Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati

Bone marrow transplantation (Basingstoke), 2020-10, Vol.55 (10), p.1900-1905

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia

The New England journal of medicine, 2012-04, Vol.366 (15), p.1371-1381

2012

Link zum Volltext

Verfügbarkeit prüfen

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy

Haematologica (Roma), 2020-09, Vol.105 (9), p.2200-2204

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5168-5174

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4755-4761

2010

Link zum Volltext

Verfügbarkeit prüfen

Collateral effects of COVID‐19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delay

Pediatric blood & cancer, 2020-08, Vol.67 (8), p.e28482-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

Haematologica (Roma), 2013-08, Vol.98 (8), p.1226

2013

Link zum Volltext

Verfügbarkeit prüfen

Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.536-543

2021

Link zum Volltext

Verfügbarkeit prüfen

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia

Frontiers in oncology, 2022-07, Vol.12, p.913487-913487

2022

Link zum Volltext

Verfügbarkeit prüfen

Closing the circle for ETP ALL

Blood, 2023-12, Vol.142 (24), p.2039

2023

Link zum Volltext

Verfügbarkeit prüfen

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO

Mediterranean journal of hematology and infectious diseases, 2022, Vol.14 (1), p.e2022027-e2022027

2022

Link zum Volltext

Verfügbarkeit prüfen

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?

Haematologica (Roma), 2022-02, Vol.107 (2), p.356-357

2022

Link zum Volltext

Verfügbarkeit prüfen

Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.1544-1544

2018

Link zum Volltext

Verfügbarkeit prüfen

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

EBioMedicine, 2022-09, Vol.83, p.104224-104224, Article 104224

2022

Link zum Volltext

Verfügbarkeit prüfen

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009‐2017)

HemaSphere, 2023-08, Vol.7 (S3), p.e1005163-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Droplet Digital PCR Improves IG‐/TR‐based MRD Risk Definition in Childhood B‐cell Precursor Acute Lymphoblastic Leukemia

HemaSphere, 2021-03, Vol.5 (3), p.e543-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(179)

Publikationsform

Sprache

Englisch
(208)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(143)
Science & Technology
(143)
Humans
(119)
Child
(93)
Hematology
(92)
Male
(71)
Oncology
(71)
Female
(68)
Child, Preschool
(63)
Infant
(54)
Adolescent
(53)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(47)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Pediatrics
(45)
Acute Lymphoblastic Leukemia
(38)
Prognosis
(36)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Hematologic And Hematopoietic Diseases
(33)
Treatment Outcome
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati

Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy

Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000)

Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial

Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005

Collateral effects of COVID‐19 pandemic in pediatric hematooncology: Fatalities caused by diagnostic delay

Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts

What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study

Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP

Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia

The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results

FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)

Closing the circle for ETP ALL

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO

Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?

Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia

Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009‐2017)

Droplet Digital PCR Improves IG‐/TR‐based MRD Risk Definition in Childhood B‐cell Precursor Acute Lymphoblastic Leukemia

Suchergebnisse filtern